Immunic, Inc.
IMUX· Nasdaq
Released May 11, 2023, before the open
10-Q filed May 11, 2023, 41 days after period end · 0001280776-23-000010
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$25.27M | -$20.81M | -$34.53M | -$8.49M |
| EPS Diluted | -$0.58 | -$0.74 | -$1.63 | -$0.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR